fda drug shortages semaglutide injection resolved date 2025 GLP-1 Drugs: Ohio Board of Pharmacy Issues FAQs for Compounders The GLP-1 shortage is real.

Other common side effects include constipation, diarrhea, and acid reflux

A: Yes, as a GH-releasing agent, it is banned by the World Anti-Doping Agency (WADA) in competitive sports

It has accelerated interest in earlier intervention, vascular health strategies, exploring different GLP-1 formulations, and combination approaches that pair GLP-1s with complementary lifestyle or pharmacological synergists

Unresolved questions It remains to be established whether CNS symptoms reported in some patients with gamma-glutamylcysteine synthetase are related to the enzyme defect or not

Same total weight lost, dramatically different body composition outcome

Zepbound KwikPen precision only